RxDoctor Payments Data

Randell Scott, MD

Internal Medicine · Flagstaff, AZNPI 1235138744

Payments from drug & device makers

$4,113in general payments, 2019–2025

Across 260 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$863
  • AstraZeneca$671
  • Lilly USA, LLC$421
  • Amgen$376
  • Amarin Pharma, Inc.$338
  • AbbVie$282
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$4,08799%
  • Education$60%
  • Entertainment$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,113 in reported general payments places this provider in the 90th percentile of 2,212 internal medicine providers in Arizona.

See all internal medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$290,050
Medicare patients
313
Services billed
5,454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban61$73,413
TrulicityDulaglutide25$32,703
LinzessLinaclotide18$21,634
JanuviaSitagliptin Phosphate12$18,154
Nurtec OdtRimegepant Sulfate17$17,811
AbrysvoRsv Vacc, Pref A And Pref B/Pf47$14,948
Breo ElliptaFluticasone/Vilanterol11$8,992
ShingrixVaricella-Zoster Ge/As01b/Pf36$7,880
SynthroidLevothyroxine Sodium82$7,303
Repatha SureclickEvolocumab13$7,057
Fluticasone-SalmeterolFluticasone Propion/Salmeterol25$6,753
Liothyronine Sodium95$4,512
Levothyroxine Sodium390$3,773
Potassium Chloride100$3,161
Atorvastatin Calcium330$3,052

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt, Abrysvo$863$106,173125 claims
Lilly USA, LLCTrulicity$421$32,70325 claims
AbbVieLinzess, Synthroid$282$28,937100 claims
MerckJanuvia$96$18,15412 claims
GSKBreo Ellipta, Shingrix$209$16,87247 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,212 internal medicine providers in Arizona.

Other internal medicine in Flagstaff

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →